As of 2024-12-11, the Intrinsic Value of Conmed Corp (CNMD) is
52.97 USD. This CNMD valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 74.74 USD, the upside of Conmed Corp is
-29.10%.
The range of the Intrinsic Value is 28.92 - 116.77 USD
52.97 USD
Intrinsic Value
CNMD Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
28.92 - 116.77 |
52.97 |
-29.1% |
| DCF (Growth 10y) |
41.34 - 138.84 |
68.26 |
-8.7% |
| DCF (EBITDA 5y) |
57.27 - 82.86 |
71.56 |
-4.3% |
| DCF (EBITDA 10y) |
62.62 - 98.43 |
80.87 |
8.2% |
| Fair Value |
106.62 - 106.62 |
106.62 |
42.65% |
| P/E |
78.00 - 214.35 |
114.49 |
53.2% |
| EV/EBITDA |
66.09 - 176.24 |
138.62 |
85.5% |
| EPV |
39.77 - 66.00 |
52.89 |
-29.2% |
| DDM - Stable |
28.74 - 82.78 |
55.76 |
-25.4% |
| DDM - Multi |
29.21 - 65.43 |
40.39 |
-46.0% |
CNMD Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
2,308.72 |
| Beta |
0.11 |
| Outstanding shares (mil) |
30.89 |
| Enterprise Value (mil) |
3,211.06 |
| Market risk premium |
4.60% |
| Cost of Equity |
11.01% |
| Cost of Debt |
4.47% |
| WACC |
8.81% |